What You Should Know:
– Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, has introduced the next version of Concentriq® AP.
– The release includes new functionality that advances the impact of AI in shaping…
Continue Reading
Jonathan Govette, Founder and CEO of Oatmeal Health The Persistent Challenge of Healthcare Access and Cancer Screening Disparities In the United States, the healthcare landscape remains plagued by significant disparities, particularly for underserved populations….
Continue Reading
Background: Cancer pain remains highly prevalent and persistent throughout survivorship, and it is crucial to investigate the potential of leveraging the advanced features of mobile health (mHealth) apps to empower individuals to self-manage their…
Continue Reading
Thyme Care, a value-based cancer care company, has secured $95 million in Series C funding, which it will use to grow its business, the company announced Tuesday.
Nashville, Tennessee-based Thyme Care, founded in 2020, partners…
Continue Reading
What You Should Know:
– Thyme Care, a leading value-based cancer care enabler raises $95M in funding capital led by Concord Health Partners, with participation from existing investors including CVS Health® Ventures, Town Hall Ventures,…
Continue Reading
What You Should Know:
– COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at revolutionizing precision medicine across Texas Oncology’s community cancer centers.
– Leveraging COTA’s AI-powered curation engine,…
Continue Reading
Virtual patients and digital patients/twins are two similar concepts gaining increasing attention in health care with goals to accelerate drug development and improve patients’ survival, but with their own limitations. Although methods have been…
Continue Reading
What You Should Know: – Philips IntelliSite Pathology 5.1 has received 510(k) clearance from the FDA, solidifying its position as the most widely deployed digital pathology solution for primary diagnosis globally. – With over…
Continue Reading
Introduction
The radiotherapy market is experiencing significant growth, driven by an increasing incidence of cancer and advancements in technology. According to a recent analysis by Mordor Intelligence, the market is expected to expand substantially from…
What You Should Know:
– GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions, is excited to introduce MIM Symphony HDR Prostate to support high dose-rate (HDR) brachytherapy.
– This innovative solution aims…
Continue Reading
